Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yuchen Cao, Qixin Deng, Shixue Dai
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)CoronavirusMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunogenicitySevere acute respiratory syndrome coronavirusOutbreakDrug2019-20 coronavirus outbreakHydroxychloroquineAntiviral drugClinical trialInfectious disease (medical specialty)PneumoniaIntensive care medicineDrug repositioningBetacoronavirusImmunologyVirusDiseasePharmacologyInternal medicineImmune systemSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and Effects